Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits.

Gray TR, Eiden RD, Leonard KE, Connors G, Shisler S, Huestis MA.

Nicotine Tob Res. 2010 Jun;12(6):658-64. doi: 10.1093/ntr/ntq068. Epub 2010 Apr 28.

2.

Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes.

Himes SK, Stroud LR, Scheidweiler KB, Niaura RS, Huestis MA.

J Pediatr. 2013 May;162(5):970-5. doi: 10.1016/j.jpeds.2012.10.045. Epub 2012 Dec 1.

3.

Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures.

Gray TR, Magri R, Shakleya DM, Huestis MA.

Clin Chem. 2008 Dec;54(12):2018-27. doi: 10.1373/clinchem.2008.109173. Epub 2008 Oct 9.

4.

Determination of nicotine and cotinine in meconium from Greek neonates and correlation with birth weight and gestational age at birth.

Tsinisizeli N, Sotiroudis G, Xenakis A, Lykeridou KE.

Chemosphere. 2015 Jan;119:1200-7. doi: 10.1016/j.chemosphere.2014.09.094. Epub 2014 Nov 1.

PMID:
25460762
5.

Nicotine and its metabolites in amniotic fluid at birth--assessment of prenatal tobacco smoke exposure.

Köhler E, Avenarius S, Rabsilber A, Gerloff C, Jorch G.

Hum Exp Toxicol. 2010 May;29(5):385-91. doi: 10.1177/0960327110363326. Epub 2010 Feb 17.

PMID:
20164157
6.

Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.

Gray TR, Eiden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA.

Clin Chem. 2010 Sep;56(9):1442-50. doi: 10.1373/clinchem.2010.147876. Epub 2010 Jul 13.

7.

Nicotine and metabolites in paired umbilical cord tissue and meconium specimens.

Marin SJ, Christensen RD, Baer VL, Clark CJ, McMillin GA.

Ther Drug Monit. 2011 Feb;33(1):80-5. doi: 10.1097/FTD.0b013e3182055f14.

PMID:
21192312
8.

Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry.

Gray TR, Shakleya DM, Huestis MA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 15;863(1):107-14. doi: 10.1016/j.jchromb.2008.01.001. Epub 2008 Jan 16.

9.

Assessment of prenatal tobacco smoke exposure by determining nicotine and its metabolites in meconium.

Köhler E, Avenarius S, Rabsilber A, Gerloff C, Jorch G.

Hum Exp Toxicol. 2007 Jun;26(6):535-44.

PMID:
17698949
10.

Maternal smoking during pregnancy and nicotine and cotinine concentrations in maternal and neonatal hair.

Jacqz-Aigrain E, Zhang D, Maillard G, Luton D, André J, Oury JF.

BJOG. 2002 Aug;109(8):909-11.

11.

Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study.

Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria AM, Della Grotta SA, Strauss A, Haning WF, Lester BM, Huestis MA.

Ther Drug Monit. 2009 Dec;31(6):769-75. doi: 10.1097/FTD.0b013e3181bb438e.

12.

Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking.

Eliopoulos C, Klein J, Chitayat D, Greenwald M, Koren G.

Clin Invest Med. 1996 Aug;19(4):231-42.

PMID:
8853571
13.

Measurement of nicotine, cotinine and trans-3'-hydroxycotinine in meconium by liquid chromatography-tandem mass spectrometry.

Xia Y, Xu M, Alexander RR, Bernert JT.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jul 15;879(22):2142-8. doi: 10.1016/j.jchromb.2011.05.054. Epub 2011 Jun 12.

PMID:
21689995
14.

A prospective cohort study of biomarkers of prenatal tobacco smoke exposure: the correlation between serum and meconium and their association with infant birth weight.

Braun JM, Daniels JL, Poole C, Olshan AF, Hornung R, Bernert JT, Xia Y, Bearer C, Barr DB, Lanphear BP.

Environ Health. 2010 Aug 27;9:53. doi: 10.1186/1476-069X-9-53.

15.

Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking.

Ostrea EM Jr, Knapp DK, Romero A, Montes M, Ostrea AR.

J Pediatr. 1994 Mar;124(3):471-6.

PMID:
8120724
16.

Detection of cotinine in neonate meconium as a marker for nicotine exposure in utero.

Sherif NA, Kamel SM, Al-Ashkar OS, Sharaki OA, Seif EA, Hegazy EA.

East Mediterr Health J. 2004 Jan-Mar;10(1-2):96-105.

PMID:
16201714
17.

Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography.

Baranowski J, Pochopień G, Baranowska I.

J Chromatogr B Biomed Sci Appl. 1998 Apr 10;707(1-2):317-21.

PMID:
9613966
18.

Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes.

Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA.

Clin Pharmacol Ther. 2008 Nov;84(5):604-12. doi: 10.1038/clpt.2008.156. Epub 2008 Aug 13.

19.

Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke.

Chan D, Caprara D, Blanchette P, Klein J, Koren G.

Clin Biochem. 2004 Jun;37(6):429-38. Review.

PMID:
15183290
20.

Use of meconium in perinatal epidemiology: potential benefits and pitfalls.

Park BY, Lee BK.

Ann Epidemiol. 2014 Dec;24(12):878-81. doi: 10.1016/j.annepidem.2014.09.009. Epub 2014 Sep 28.

PMID:
25444889
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk